Cardinal Health, Inc.

Healthcare · Medical - Distribution

Overall research band Weak

Quality Mixed

Valuation Weak

Balance sheet Very weak

Market confirmation Strong

One-minute company read

What this report can tell you now

What the company does

Cardinal Health, Inc. is a global provider of healthcare services and products, operating primarily through its Pharmaceutical and Medical divisions. The Pharmaceutical segment distributes branded, generic, and specialty pharmaceuticals, over-the-counter health and consumer goods, and offers specialized services to pharmaceutical manufacturers and healthcare providers, including management of nuclear pharmacies and radiopharmaceutical production. It also provides medication therapy management, patient outcomes services, and pharmacy management solutions. The Medical division manufactures, sources, and supplies Cardinal Health-branded and national brand medical, surgical, and laboratory products, such as gloves, syringes, wound care supplies, and procedure kits. Cardinal Health serves hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and home care patients, generating revenue through the sale and distribution of healthcare products and related services.

The current research profile is Turnaround Candidate, with elevated leverage. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

Recent market behavior is the strongest visible confirmation. Check whether it agrees with the underlying business evidence.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

Read the latest filing or company update.
Check the financial period behind each metric.
Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

Operating margin1.0%Model input; read with the evidence status and period context.

Revenue CAGR · 4 years8.2%Model input; read with the evidence status and period context.

FCF margin0.8%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.

Evidence detailSee exact inputs, source context, and model-aware metrics.

HistoryReview score and research changes over time.

MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.